Condition (MeSH)
Fluorosis, Dental
ClinicalTrials.gov lists 22 trials for Fluorosis, Dental or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
22 of the 22 trials are tagged with Fluorosis, Dental itself; the rest are tagged with a narrower condition beneath it.
When did Fluorosis, Dental trials start? (15)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 4 |
| 2023 | 1 |
| 2022 | 1 |
| 2019 | 3 |
| 2018 | 1 |
| 2017 | 1 |
| 2015 | 1 |
| 2014 | 1 |
| 2013 | 1 |
Showing 10 of 15 earlier years.
No forecast is made for this condition: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 22 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Fluorosis, Dental trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 3 |
| Phase 3 | 1 |
| Phase 4 | 2 |
| Not applicable | 12 |
| Observational | 4 |
How many Fluorosis, Dental trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
| Completed | 17 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Fluorosis, Dental? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Potassium Nitrate Toothpaste | 1 |
Interventions as named in the registry (11)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Opalustre | 3 |
| MI Paste Plus | 2 |
| Antivet | 2 |
| Regular toothpastes | 1 |
| Double distilled water | 1 |
Showing 5 of 11 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Fluorosis, Dental? (27)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Microabrasion in the management of enamel discolorations in paediatric dentistry: a systematic review. | The Journal of clinical pediatric dentistry | 2023 | Yes |
| Efficacy of Calcium-Containing Eggshell Powder Supplementation on Urinary Fluoride and Fluorosis Symptoms in Women in the Ethiopian Rift Valley. | Nutrients | 2021 | Yes |
| Inferring marginal association with paired and unpaired clustered data. | Statistical methods in medical research | 2018 | Yes |
| Comparative evaluation of esthetic changes in nonpitted fluorosis stains when treated with resin infiltration, in-office bleaching, and combination therapies. | Journal of esthetic and restorative dentistry : official publication of the American Academy of Esthetic Dentistry ... [et al.] | 2017 | Yes |
| A comparison of various minimally invasive techniques for the removal of dental fluorosis stains in children. | Journal of the Indian Society of Pedodontics and Preventive Dentistry | 2017 | Yes |
Showing 5 of 27 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.